These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 18028446

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step.
    Borkow G, Vijayabaskar V, Lara HH, Kalinkovich A, Lapidot A.
    Antiviral Res; 2003 Nov; 60(3):181-92. PubMed ID: 14638394
    [Abstract] [Full Text] [Related]

  • 4. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
    Hatse S, Princen K, De Clercq E, Rosenkilde MM, Schwartz TW, Hernandez-Abad PE, Skerlj RT, Bridger GJ, Schols D.
    Biochem Pharmacol; 2005 Sep 01; 70(5):752-61. PubMed ID: 16011832
    [Abstract] [Full Text] [Related]

  • 5. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.
    Dong CZ, Kumar S, Choi WT, Madani N, Tian S, An J, Sodroski JG, Huang Z.
    J Med Chem; 2005 Dec 15; 48(25):7923-4. PubMed ID: 16335916
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication.
    Bridger GJ, Skerlj RT, Hernandez-Abad PE, Bogucki DE, Wang Z, Zhou Y, Nan S, Boehringer EM, Wilson T, Crawford J, Metz M, Hatse S, Princen K, De Clercq E, Schols D.
    J Med Chem; 2010 Feb 11; 53(3):1250-60. PubMed ID: 20043638
    [Abstract] [Full Text] [Related]

  • 7. Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sites.
    Berchanski A, Lapidot A.
    J Mol Model; 2009 Mar 11; 15(3):281-94. PubMed ID: 19057930
    [Abstract] [Full Text] [Related]

  • 8. Peptide-lead CXCR4 antagonists with high anti-HIV activity.
    Fujii N, Tamamura H.
    Curr Opin Investig Drugs; 2001 Sep 11; 2(9):1198-202. PubMed ID: 11717804
    [Abstract] [Full Text] [Related]

  • 9. Anti-HIV activity and conformational studies of peptides derived from the C-terminal sequence of SDF-1.
    Dettin M, Pasquato A, Scarinci C, Zanchetta M, De Rossi A, Di Bello C.
    J Med Chem; 2004 Jun 03; 47(12):3058-64. PubMed ID: 15163187
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cyclic zinc-dithiocarbamate-S,S'-dioxide blocks CXCR4-mediated HIV-1 infection.
    Takamune N, Misumi S, Shoji S.
    Biochem Biophys Res Commun; 2000 Jun 07; 272(2):351-6. PubMed ID: 10833417
    [Abstract] [Full Text] [Related]

  • 13. NeoR6 inhibits HIV-1-CXCR4 interaction without affecting CXCL12 chemotaxis activity.
    Lapidot A, Peled A, Berchanski A, Pal B, Kollet O, Lapidot T, Borkow G.
    Biochim Biophys Acta; 2008 Jun 07; 1780(6):914-20. PubMed ID: 18410746
    [Abstract] [Full Text] [Related]

  • 14. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
    Choi WT, Tian S, Dong CZ, Kumar S, Liu D, Madani N, An J, Sodroski JG, Huang Z.
    J Virol; 2005 Dec 07; 79(24):15398-404. PubMed ID: 16306611
    [Abstract] [Full Text] [Related]

  • 15. The role of positively charged residues in CXCR4 recognition probed with synthetic peptides.
    Luo Z, Zhou N, Luo J, Hall JW, Huang Z.
    Biochem Biophys Res Commun; 1999 Oct 05; 263(3):691-5. PubMed ID: 10512741
    [Abstract] [Full Text] [Related]

  • 16. Identification of a D-amino acid decapeptide HIV-1 entry inhibitor.
    Boggiano C, Jiang S, Lu H, Zhao Q, Liu S, Binley J, Blondelle SE.
    Biochem Biophys Res Commun; 2006 Sep 08; 347(4):909-15. PubMed ID: 16854380
    [Abstract] [Full Text] [Related]

  • 17. Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy.
    Lapidot A, Vijayabaskar V, Litovchick A, Yu J, James TL.
    FEBS Lett; 2004 Nov 19; 577(3):415-21. PubMed ID: 15556620
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Discovery of novel, highly potent and selective beta-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles.
    DeMarco SJ, Henze H, Lederer A, Moehle K, Mukherjee R, Romagnoli B, Robinson JA, Brianza F, Gombert FO, Lociuro S, Ludin C, Vrijbloed JW, Zumbrunn J, Obrecht JP, Obrecht D, Brondani V, Hamy F, Klimkait T.
    Bioorg Med Chem; 2006 Dec 15; 14(24):8396-404. PubMed ID: 17010618
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.